immunocompromised

The Changing Landscape of Acute Invasive Fungal Rhinosinusitis: Rising Detection and Declining Mortality

By MedXY 01/25/2026

A landmark systematic review of over 48,000 patients reveals that while the proportion of AIFRS in immunocompromised populations is increasing, mortality rates have dropped significantly since 2013 due to diagnostic and therapeutic advancements.

Infectious Diseases news Otorhinolaryngology

AIFRS Mortality Drops as Detection Rates Climb: New Insights into Acute Invasive Fungal Rhinosinusitis

By MedXY 01/25/2026

A comprehensive meta-analysis reveals that while the proportion of AIFRS in immunocompromised patients has risen to 16.6% in recent years, mortality has significantly decreased to 28.2% due to improved diagnostic and therapeutic strategies.

Clinical Updates news Public Health Respiratory

Durability and Decay: Evaluating Long-term RSV Vaccine Effectiveness in a Large Real-World Cohort of US Veterans

By MedXY 01/01/2026

This review analyzes the long-term effectiveness of RSV vaccination among US Veterans, revealing significant protection against severe outcomes that wanes over two seasons, particularly in immunocompromised populations.

Infectious Diseases news Public Health

IDSA 2025 Update: Stronger Flu and RSV Vaccine Recommendations for Immunocompromised People — What Clinicians Need to Know

By MedXY 11/23/2025

The Infectious Diseases Society of America now recommends annual high-dose or adjuvanted influenza vaccine and a single RSV dose for most immunocompromised persons; timing around immunosuppression and household immunization are emphasized.